The story of Viagra, formerly marketed by copyright, presents a fascinating case study for investors considering the pharmaceutical arena . Although its early success and creation of vast in sales, the exclusivity expiration has opened the way for alternative medications, significantly diminishing earnings prospects . This shift raises concerns abo